Beta Drugs Market Cap

Beta Drugs has a market cap or net worth of 20.09 billion as of June 18, 2026. Its market cap has increased by 5.61% in one year.

Market Cap

20.09B

Enterprise Value

20.32B

Revenue

3.85B

Ranking

n/a

PE Ratio

48.64

Stock Price

1,990.20

Market Cap Chart

Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 20.09B, an increase of 2,093.29%. That is a compound annual growth rate of 42.87%.

Market Cap History

Date	Market Cap	% Change
Jun 19, 2026	20.09B	28.47%
Dec 31, 2025	15.64B	-19.04%
Dec 31, 2024	19.31B	36.67%
Dec 29, 2023	14.13B	107.04%
Dec 30, 2022	6.83B	10.89%
Dec 31, 2021	6.16B	497.76%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 27, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Oct 25, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Aarti Pharmalabs	59.70B
Innova Captab	53.39B
Orchid Pharma	51.14B
RPG Life Sciences	37.68B
Solara Active Pharma Sciences	27.34B
Indoco Remedies	21.42B
Sakar Healthcare	17.71B
Windlas Biotech	16.67B

Market Cap Rankings